{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:29:43Z","timestamp":1790688583934,"version":"4.1.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Higher serum \u03b22-microglobulin (B2M) concentrations are associated with higher mortality in the general population, non-dialyzed chronic kidney disease patients and patients receiving hemodialysis (HD). However, this relationship among patients on peritoneal dialysis (PD) has not been validated.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We collected baseline data for 3,011 prevalent PD patients from a nationwide dialysis registry in Japan at the end of 2010. Clinical outcomes for 9 years were then evaluated using the registry at the end of 2011 to 2019. All-cause and cardiovascular (CV) mortality was assessed using Cox regression analysis and competing-risks regression analysis, respectively. We used multiple imputation to deal with missing covariate data.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>During a median follow-up of 87 months, 2,054 patients transferred to combined therapy with PD and HD or HD directly. A total of 3,011 patients, 1,235 (41.0%) died, including 437 patients (14.5%) from CV causes. Among them, 612 patients died after transfer to other dialysis modalities. Univariate analyses revealed no significant association between serum B2M and mortality, whereas higher serum B2M was independently associated with both all-cause and CV mortalities in adjusted models. However, the significant association between serum B2M and CV mortality disappeared in analysis treating serum B2M as a categorical variable. The effect of serum B2M on all-cause mortality was significantly higher among patients with higher urinary volume and a significant interaction was evident.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Using a large-scale registry, we found that serum B2M contributes tenuously but significantly to worse outcome and residual kidney function significantly affects this relationship. On the contrary, serum B2M <jats:italic>per se<\/jats:italic> had no predictive value for patient outcome in prevalent PD patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0266882","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T17:40:56Z","timestamp":1649958056000},"page":"e0266882","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Association between serum \u03b22-microglobulin and mortality in Japanese peritoneal dialysis patients: A cohort study"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5602-8104","authenticated-orcid":true,"given":"Yukio","family":"Maruyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yokoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Minakuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosaku","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,4,14]]},"reference":[{"issue":"5","key":"pone.0266882.ref001","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/089686080602600502","article-title":"Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis","volume":"26","author":"WK Lo","year":"2006","journal-title":"Perit Dial Int"},{"issue":"3","key":"pone.0266882.ref002","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/0896860819895364","article-title":"International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis","volume":"40","author":"EA Brown","year":"2020","journal-title":"Perit Dial Int"},{"issue":"4","key":"pone.0266882.ref003","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ndt\/gfv318","article-title":"beta2 microglobulin amyloidosis: an update 30 years later","volume":"31","author":"M Jadoul","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"pone.0266882.ref004","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0272-6386(89)80119-2","article-title":"Beta 2-microglobulin levels in patients with renal insufficiency","volume":"13","author":"S Acchiardo","year":"1989","journal-title":"Am J Kidney Dis"},{"issue":"5\u20136","key":"pone.0266882.ref005","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0731-7085(00)00550-1","article-title":"Cystatin C, beta 2-microglobulin, and retinol-binding protein as indicators of glomerular filtration rate: comparison with plasma creatinine","volume":"24","author":"C Donadio","year":"2001","journal-title":"Journal of pharmaceutical and biomedical analysis"},{"issue":"3\u20134","key":"pone.0266882.ref006","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1081\/JDI-100104725","article-title":"Reappraisal of serum beta2-microglobulin as marker of GFR","volume":"23","author":"C Bianchi","year":"2001","journal-title":"Renal failure"},{"issue":"2","key":"pone.0266882.ref007","first-page":"169","article-title":"Serum low-molecular-weight proteins in haemodialysis patients: effect of residual renal function","volume":"3","author":"PH Brown","year":"1988","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"pone.0266882.ref008","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1159\/000187533","article-title":"Serum beta-2-microglobulin level and residual renal function in peritoneal dialysis","volume":"65","author":"G Amici","year":"1993","journal-title":"Nephron"},{"issue":"1","key":"pone.0266882.ref009","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/j.ajkd.2013.01.016","article-title":"Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults","volume":"62","author":"MC Foster","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"pone.0266882.ref010","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/j.ajkd.2011.11.042","article-title":"Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population","volume":"59","author":"BC Astor","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"pone.0266882.ref011","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/j.ajkd.2016.01.015","article-title":"Serum beta-Trace Protein and beta2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study","volume":"68","author":"MC Foster","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"pone.0266882.ref012","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1681\/ASN.2005020132","article-title":"Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study","volume":"17","author":"AK Cheung","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 7","key":"pone.0266882.ref013","first-page":"16","article-title":"Section II. Haemodialysis adequacy","volume":"17","author":"European Best Practice Guidelines Expert Group on Hemodialysis ERA","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"pone.0266882.ref014","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000499830","article-title":"Single Session and Weekly Beta 2-Microglobulin Removal with Different Dialytic Procedures: Comparison between High-Flux Standard Bicarbonate Hemodialysis, Post-Dilution Hemodiafiltration, Short Frequent Hemodialysis with NxStage Technology and Automated Peritoneal Dialysis","volume":"48","author":"CCM Brunati","year":"2019","journal-title":"Blood Purif"},{"issue":"3","key":"pone.0266882.ref015","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.V113556","article-title":"Predictors of loss of residual renal function among new dialysis patients","volume":"11","author":"LM Moist","year":"2000","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"pone.0266882.ref016","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.kint.2015.10.011","article-title":"Estimating residual kidney function in dialysis patients without urine collection","volume":"89","author":"T Shafi","year":"2016","journal-title":"Kidney Int"},{"key":"pone.0266882.ref017","article-title":"Serum beta2-microglobulin as a predictor of residual kidney function in peritoneal dialysis patients","author":"DA Jaques","year":"2020","journal-title":"Journal of nephrology"},{"issue":"2","key":"pone.0266882.ref018","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5414\/CNP69121","article-title":"Serum beta2 microglobulin (beta2MG) level is a potential predictor for encapsulating peritoneal sclerosis (EPS) in peritoneal dialysis patients","volume":"69","author":"K Yokoyama","year":"2008","journal-title":"Clin Nephrol"},{"issue":"11","key":"pone.0266882.ref019","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/nep.12911","article-title":"Risk factors for encapsulating peritoneal sclerosis: Analysis of a 36-year experience in a University Hospital","volume":"22","author":"M Nakao","year":"2017","journal-title":"Nephrology (Carlton)"},{"issue":"2","key":"pone.0266882.ref020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000439060","article-title":"Serum beta2-Microglobulin Predicts Mortality in Peritoneal Dialysis Patients: A Prospective Cohort Study","volume":"42","author":"ES Koh","year":"2015","journal-title":"Am J Nephrol"},{"issue":"1","key":"pone.0266882.ref021","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/ndt\/gfy193","article-title":"Lower serum beta-2 microglobulin levels are associated with worse survival in incident peritoneal dialysis patients","volume":"34","author":"TI Chang","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"pone.0266882.ref022","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1744-9987.2012.01143.x","article-title":"An overview of regular dialysis treatment in Japan (as of 31 December 2010)","volume":"16","author":"S Nakai","year":"2012","journal-title":"Ther Apher Dial"},{"issue":"6","key":"pone.0266882.ref023","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1744-9987.2010.00901.x","article-title":"2009 Japanese Society for Dialysis Therapy guidelines for peritoneal dialysis","volume":"14","author":"Working Group Committee for Preparation of Guidelines for Peritoneal Dialysis JSfDT, Japanese Society for Dialysis T","year":"2010","journal-title":"Ther Apher Dial"},{"issue":"446","key":"pone.0266882.ref024","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"J Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"pone.0266882.ref025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1536867X0400400201","article-title":"Cumulative incidence estimation in the presence of competing risks","volume":"4","author":"V Coviello","year":"2004","journal-title":"Stata J"},{"issue":"4","key":"pone.0266882.ref026","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/1536867X1401400410","article-title":"Analysis of partially observed clustered data using generalized estimating equations and multiple imputation","volume":"14","author":"K Aloisio","year":"2014","journal-title":"Stata J"},{"issue":"10","key":"pone.0266882.ref027","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1681\/ASN.V12102158","article-title":"Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study","volume":"12","author":"JM Bargman","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"pone.0266882.ref028","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.V1351307","article-title":"Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial","volume":"13","author":"R Paniagua","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"Pt B","key":"pone.0266882.ref029","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-4684-3300-5_8","article-title":"Beta 2-microglobulin of lymphocytes","volume":"73","author":"TP Conway","year":"1976","journal-title":"Advances in experimental medicine and biology"},{"issue":"1","key":"pone.0266882.ref030","first-page":"47","article-title":"beta2-Microglobulin production by highly purified human T and B lymphocytes in cell culture stimulated with various mitogens","volume":"36","author":"K Kin","year":"1979","journal-title":"Immunology"},{"issue":"1","key":"pone.0266882.ref031","first-page":"38","article-title":"CONUT: a tool for controlling nutritional status. First validation in a hospital population","volume":"20","author":"J Ignacio de Ulibarri","year":"2005","journal-title":"Nutricion hospitalaria"},{"issue":"3","key":"pone.0266882.ref032","doi-asserted-by":"crossref","first-page":"e22056","DOI":"10.1002\/jcla.22056","article-title":"Associations among Serum Beta 2 Microglobulin, Malnutrition, Inflammation, and Advanced Cardiovascular Event in Patients with Chronic Kidney Disease","volume":"31","author":"HC Wu","year":"2017","journal-title":"Journal of clinical laboratory analysis"},{"issue":"4","key":"pone.0266882.ref033","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2215\/CJN.08700812","article-title":"Comparison of serum concentrations of beta-trace protein, beta2-microglobulin, cystatin C, and creatinine in the US population","volume":"8","author":"SP Juraschek","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"pone.0266882.ref034","article-title":"Prognostic value of beta-2 microglobulin on mortality in chronic kidney disease patients: A systematic review and meta-analysis","author":"J Zhang","year":"2021","journal-title":"Ther Apher Dial"},{"issue":"4","key":"pone.0266882.ref035","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0272-6386(99)70395-1","article-title":"Significance of serum creatinine values in new end-stage renal disease patients","volume":"34","author":"JC Fink","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"pone.0266882.ref036","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1523-1755.2002.00176.x","article-title":"Peritoneal and hemodialysis: II. Mortality risk associated with initial patient characteristics","volume":"61","author":"JL Xue","year":"2002","journal-title":"Kidney Int"},{"issue":"3","key":"pone.0266882.ref037","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1523-1755.2003.00803.x","article-title":"Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients","volume":"63","author":"K Kalantar-Zadeh","year":"2003","journal-title":"Kidney Int"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0266882","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T17:41:31Z","timestamp":1649958091000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0266882"}},"subtitle":[],"editor":[{"given":"Kojiro","family":"Nagai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,4,14]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0266882","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,14]]}}}